Last reviewed · How we verify
Traditional Vitamin D Therapy
Traditional Vitamin D Therapy is a Vitamin D supplement Small molecule drug developed by Amgen. It is currently FDA-approved for Vitamin D deficiency, Osteoporosis prevention and treatment, Hypoparathyroidism.
Vitamin D supplementation increases serum 25-hydroxyvitamin D levels to support calcium homeostasis, bone mineralization, and immune function.
Vitamin D supplementation increases serum 25-hydroxyvitamin D levels to support calcium homeostasis, bone mineralization, and immune function. Used for Vitamin D deficiency, Osteoporosis prevention and treatment, Hypoparathyroidism.
At a glance
| Generic name | Traditional Vitamin D Therapy |
|---|---|
| Sponsor | Amgen |
| Drug class | Vitamin D supplement |
| Target | Vitamin D receptor (VDR) |
| Modality | Small molecule |
| Therapeutic area | Endocrinology / Bone Health |
| Phase | FDA-approved |
Mechanism of action
Vitamin D is converted in the liver to 25-hydroxyvitamin D (the major circulating form) and then in the kidneys to 1,25-dihydroxyvitamin D (the active hormonal form), which binds to the vitamin D receptor to regulate calcium and phosphate absorption in the intestines and bone metabolism. This supports skeletal health and modulates immune and cardiovascular function.
Approved indications
- Vitamin D deficiency
- Osteoporosis prevention and treatment
- Hypoparathyroidism
Common side effects
- Hypercalcemia
- Hypercalciuria
- Nausea
- Constipation
Key clinical trials
- Cardioprotective Effect of Melatonin Versus Vitamin D in Breast Cancer Patients Receiving Doxorubicin (NA)
- Progressive Resisted Exercise Plus Aerobic Exercise on Osteoporotic Systemic Lupus Erythmatosus (NA)
- Vitamin D3 For CGD Patients With BCGosis/Itis (PHASE2, PHASE3)
- Hyperbaric on Pulmonary Functions in Post Covid -19 Patients. (NA)
- Dental Implants Rehabilitation in Patients With Vitamin D3 Imbalance (NA)
- Observational Study on the Use of Ivermectin as an Outpatient Treatment Option for COVID-19
- Multiprofessional Approach in Diabetes Mellitus (NA)
- Different Treatment Modalities in the Management of the Painful Crisis in Pediatric Sickle- Cell Anemia (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Traditional Vitamin D Therapy CI brief — competitive landscape report
- Traditional Vitamin D Therapy updates RSS · CI watch RSS
- Amgen portfolio CI
Frequently asked questions about Traditional Vitamin D Therapy
What is Traditional Vitamin D Therapy?
How does Traditional Vitamin D Therapy work?
What is Traditional Vitamin D Therapy used for?
Who makes Traditional Vitamin D Therapy?
What drug class is Traditional Vitamin D Therapy in?
What development phase is Traditional Vitamin D Therapy in?
What are the side effects of Traditional Vitamin D Therapy?
What does Traditional Vitamin D Therapy target?
Related
- Drug class: All Vitamin D supplement drugs
- Target: All drugs targeting Vitamin D receptor (VDR)
- Manufacturer: Amgen — full pipeline
- Therapeutic area: All drugs in Endocrinology / Bone Health
- Indication: Drugs for Vitamin D deficiency
- Indication: Drugs for Osteoporosis prevention and treatment
- Indication: Drugs for Hypoparathyroidism
- Compare: Traditional Vitamin D Therapy vs similar drugs
- Pricing: Traditional Vitamin D Therapy cost, discount & access